Conclusion and Relevance
infection
INFECTION
Among full‐vaccinated adults recent infected with COVID‐19, a daily intake of tiny quantities of oromucosal administered high polyphenolic olive oil before infection significantly improved the time to symptom resolution. This finding strongly support the appropriateness of further deep research on the use of oromucosal administered high polyphenolic olive oil as an effective immune strategy against COVID‐19.This pilot study revolves around the feasibility of a novel immune strategy against COVID‐19 consisting of the buccopharyngeal administration of olive polyphenols (OP). SARS‐CoV‐2 ability to silence the immune surveillance function played by mucosal innate immunity through dendritic cells (DC) could be hypothetically counteract by local immunomodulation with OP.
